WO1997038738A1 - Improved sanitary pad - Google Patents
Improved sanitary pad Download PDFInfo
- Publication number
- WO1997038738A1 WO1997038738A1 PCT/FR1997/000683 FR9700683W WO9738738A1 WO 1997038738 A1 WO1997038738 A1 WO 1997038738A1 FR 9700683 W FR9700683 W FR 9700683W WO 9738738 A1 WO9738738 A1 WO 9738738A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antiseptic
- hygienic protection
- protection according
- weight
- approximately
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
Definitions
- the invention relates to improved hygienic protection.
- hygienic protection the various comfort products and / or for medical use, for the use of children or adults, such as for example diapers infants and / or for adults, medical diapers, incontinence diapers, feminine protections, in particular periodic towels, periodic tampons, etc.
- the invention aims to meet this need by providing a new improved hygienic protection.
- the hygienic protection according to the invention which can be used for infant, adult and / or medical hygiene, comprising at least one impermeable outer sheet, a permeable veil and an absorbent layer disposed between said outer sheet and said permeable veil, is characterized in that it comprises one or more antiseptics.
- the antiseptic (s) used in the context of the present invention are chosen from natural antiseptics.
- the antiseptic is of natural origin and is chosen from essential oils, in particular those of vegetable origin.
- natural antiseptics which can be used in the context of the present invention, essential oils of geranium, lavender or lemongrass.
- the natural antiseptic consists essentially of essential oil of Melaleuca alternifolia.
- the essential oil of Melaleuca alternifolia is obtained in particular by steam distillation of fresh leaves and twigs of Melaleuca alternifolia, as described in particular in the publication Phytotherapy, September 1985, n ° 15, pp. 5-8.
- the natural antiseptic consists of a mixture essentially comprising, in percentage relative to the weight:
- the hygienic protection according to the invention comprises from approximately 0.2 mg to approximately 20 g of antiseptic.
- the natural antiseptic can be deposited on the hygienic protection in pure form.
- the antiseptic can be deposited on the hygienic protection in the form of a gel or dry powder or else in a diluted form, for example in aqueous solution or in anhydrous solution.
- a solubilizing agent or a solvent in particular an alcoholic solvent, for example ethyl alcohol.
- solubilizing agent is not critical in itself and it may be, in particular when the antiseptic is an essential oil, any surfactant used for liposoluble products.
- the total weight of the antiseptic solution contained in the hygienic protection according to the invention will not exceed approximately 20 g.
- the antiseptic solution comprises from approximately 1% by weight to approximately 10% by weight, relative to the total weight of the solution, essential oil of Melaleuca alternifolia in a solubilizing agent consisting of a mixture of coconut glyceryl oxyethylene, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water.
- the antiseptic solution comprises from approximately 2% by weight to approximately 30% by weight, relative to the total weight of the solution, of geranium essential oil in a solubilizing agent consisting of a mixture of coconut glycerile oxyethylene, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water.
- a solubilizing agent consisting of a mixture of coconut glycerile oxyethylene, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water.
- the hygienic protection according to the invention further comprises one or more perfumes, such as those conventionally used in cosmetic products . Mention will be made, by way of nonlimiting examples of perfumes which can be used in the context of the present invention, of the essences of lemon, lily of the valley, distilled tangerine, jasmine or lavender.
- the perfume (s) may be present in the hygienic protection of the invention, at a concentration varying between approximately 1% and approximately 5% by weight relative to the weight of the antiseptic.
- the hygienic protection of the invention further comprises a preservative, protective with regard in particular to bacteria, yeasts and / or fungi.
- the preservative can be used at a concentration varying between about 0.1% by weight and about 1% by weight relative to the weight of the antiseptic.
- the antiseptic solution can be deposited on the hygienic protection according to the invention by any means known per se.
- the antiseptic solution is deposited by spraying or else by a licking or contactless nozzle during the manufacturing process of the hygienic protection, preferably at the end of it.
- the antiseptic is advantageously deposited on the constituent elements of hygienic protection in contact with the skin or the mucous membranes.
- the antiseptic is deposited on the constituent elements of the hygienic protection having sufficient permeability to allow a transfer of the antiseptic to the skin or the mucous membranes and, thus a contact of the antiseptic with the skin or mucous membranes.
- the antiseptic can be deposited at the level of the internal veil.
- the antiseptic can be deposited at the level of the intermediate veil.
- the antiseptic is deposited on the hygienic protection in a state encapsulated in a vehicle, for example in a lipophilic polymer when using an oily antiseptic pure or diluted in an oil.
- the antiseptic can be deposited using vectors usually used in the chemical or cosmetological industry, such as liposomes or phospholipids, to allow a delayed action of the antiseptic and / or to provide a protective role for the active ingredient vis-à-vis the outside. Additional advantages and characteristics of the present invention will become apparent in the light of the more detailed description which follows of an exemplary embodiment of the present invention, given solely by way of illustration and without limitation.
- a solution containing 0.02 g of a spray solution is deposited on a children's diaper comprising an inner veil of hydrophilic polypropylene, an outer sheet of polyethylene and an absorbent layer of cellulose wadding between the inner veil and the outer sheet.
- the diaper After storage in its commercial packaging for at least one year at room temperature, the diaper shows a positive action against the pathogenic agents Staphylococcus Curreus, Escherichia Coli, Pseudomonas Aeruginosa, Cnadida Albicans and Aspergillus Niger.
Abstract
The invention concerns a sanitary pad for use in sanitary protection of infants and adults and/or for medical uses, the pad comprising at least one external impermeable sheet, a permeable skin and an absorbant layer positoned between the external sheet and the permeable skin, the characterizing feature being that it contains one or several antiseptics.
Description
Titre : Protection hygiénique perfectionnéeTitle: Advanced hygienic protection
L'invention concerne une protection hygiénique perfectionnée. Dans le cadre de la présente demande de brevet, on désignera dans ce qui suit par « protection hygiénique » les différents produits de confort et/ou à usage médical, à l'usage des enfants ou des adultes, tels que par exemple couches-culottes infantiles et/ou pour adultes, couches-culottes médicales, couches pour incontinence, protections féminines notamment serviettes périodiques, tampons périodiques, etc.The invention relates to improved hygienic protection. In the context of this patent application, the following will designate by "hygienic protection" the various comfort products and / or for medical use, for the use of children or adults, such as for example diapers infants and / or for adults, medical diapers, incontinence diapers, feminine protections, in particular periodic towels, periodic tampons, etc.
Les recherches menées depuis plusieurs années sur les matériaux et/ou les procédés de fabrication de protections hygiéniques ont abouti à des produits de plus en plus perfectionnés qui offrent à la fois de bonnes conditions de confort et d'hygiène.Research carried out for several years on materials and / or processes for manufacturing hygienic protections has resulted in increasingly sophisticated products which offer both good conditions of comfort and hygiene.
Il existe cependant toujours un besoin dans le développement de produits capables d'offrir un niveau de protection et d'hygiène encore plus important. L'invention a pour but de répondre à ce besoin en proposant une nouvelle protection hygiénique améliorée.However, there is still a need in the development of products capable of offering an even higher level of protection and hygiene. The invention aims to meet this need by providing a new improved hygienic protection.
La protection hygiénique selon l'invention, utilisable pour l'hygiène infantile, adulte et/ou l'hygiène médicale, comprenant au moins une feuille extérieure imperméable, un voile perméable et une couche absorbante disposée entre ladite feuille extérieure et ledit voile perméable, se caractérise en ce qu'elle comprend un ou plusieurs antiseptiques.The hygienic protection according to the invention, which can be used for infant, adult and / or medical hygiene, comprising at least one impermeable outer sheet, a permeable veil and an absorbent layer disposed between said outer sheet and said permeable veil, is characterized in that it comprises one or more antiseptics.
Avantageusement, le ou les antiseptiques utilisés dans le cadre de la présente invention sont choisis parmi les antiseptiques naturels.Advantageously, the antiseptic (s) used in the context of the present invention are chosen from natural antiseptics.
Selon une forme de réalisation de la présente invention, l'antiseptique est d'origine naturelle et est choisi parmi les huiles essentielles, notamment celles d'origine végétale.According to one embodiment of the present invention, the antiseptic is of natural origin and is chosen from essential oils, in particular those of vegetable origin.
On citera à titre d'exemples non limitatifs d'antiseptiques natures utilisables dans le cadre de la présente invention les huiles essentielles de géranium, de lavande ou de citronnelle. Selon une autre forme de réalisation de la présente invention, l'antiseptique naturel consiste essentiellement en huile essentielle de
Melaleuca alternifolia.Mention will be made, by way of nonlimiting examples of natural antiseptics which can be used in the context of the present invention, essential oils of geranium, lavender or lemongrass. According to another embodiment of the present invention, the natural antiseptic consists essentially of essential oil of Melaleuca alternifolia.
L'huile essentielle de Melaleuca alternifolia est obtenue notamment par distillation à la vapeur d'eau de feuilles fraiches et de rameaux du Melaleuca alternifolia, tel que décrit notamment dans la publication Phytotherapy, Septembre 1985, n° 15, pp. 5-8.The essential oil of Melaleuca alternifolia is obtained in particular by steam distillation of fresh leaves and twigs of Melaleuca alternifolia, as described in particular in the publication Phytotherapy, September 1985, n ° 15, pp. 5-8.
Selon une autre forme de réalisation de ia présente invention, l'antiseptique naturel consiste en un mélange comprenant essentiellement, en pourcentage par rapport au poids :According to another embodiment of the present invention, the natural antiseptic consists of a mixture essentially comprising, in percentage relative to the weight:
- environ 35 % de terpinène-1-ol-4 ; - environ 20 % de gamma terpinène ;- about 35% of terpinene-1-ol-4; - about 20% of gamma terpinene;
- environ 10 % d'alpha terpinène ;- about 10% of alpha terpinene;
- environ 5 % de cinéole ; et- about 5% of cineole; and
- environ 20 % de p-cymène.- about 20% p-cymene.
De préférence, la protection hygiénique selon l'invention comprend d'environ 0,2 mg à environ 20 g d'antiseptique.Preferably, the hygienic protection according to the invention comprises from approximately 0.2 mg to approximately 20 g of antiseptic.
Selon l'invention, l'antiseptique naturel peut être déposé sur la protection hygiénique sous forme pure.According to the invention, the natural antiseptic can be deposited on the hygienic protection in pure form.
Selon une forme de réalisation de la présente invention, l'antiseptique peut être déposé sur la protection hygiénique sous une forme de gel ou de poudre sèche ou encore sous une forme diluée par exemple en solution aqueuse ou en solution anhydre. En variante, il peut être dissout grâce à un agent solubilisant ou un solvant, notamment alcoolique, par exemple l'alcool éthylique.According to one embodiment of the present invention, the antiseptic can be deposited on the hygienic protection in the form of a gel or dry powder or else in a diluted form, for example in aqueous solution or in anhydrous solution. As a variant, it can be dissolved using a solubilizing agent or a solvent, in particular an alcoholic solvent, for example ethyl alcohol.
Le choix de l'agent solubilisant n'est pas critique en lui-même et il peut s'agir, notamment lorsque l'antiseptique est une huile essentielle, de tout agent tensioactif utilisé pour des produits liposolubles.The choice of the solubilizing agent is not critical in itself and it may be, in particular when the antiseptic is an essential oil, any surfactant used for liposoluble products.
De préférence, le poids total de la solution antiseptique contenue dans la protection hygiénique selon l'invention ne dépassera pas environ 20 g. Selon une forme de réalisation de la présente invention, la solution antiseptique comprend d'environ 1% en poids à environ 10 % en poids,
par rapport au poids total de la solution, d'huile essentielle de Melaleuca alternifolia dans un agent solubilisant consistant en un mélange d'oxyéthylène glycérile de coprah, d'oxyéthylène de cétylstéaryle, d'oxyéthylène d'huile de ricin hydrogénée et de l'eau distillée. Selon une autre forme de réalisation de la présente invention, la solution antiseptique comprend d'environ 2 % en poids à environ 30 % en poids, par rapport au poids total de la solution, d'huile essentielle de géranium dans un agent solubilisant consistant en un mélange d'oxyéthylène glycérile de coprah, d'oxyéthylène de cétylstéaryl, d'oxyéthylène d'huile de ricin hydrogénée et de l'eau distillée.Preferably, the total weight of the antiseptic solution contained in the hygienic protection according to the invention will not exceed approximately 20 g. According to an embodiment of the present invention, the antiseptic solution comprises from approximately 1% by weight to approximately 10% by weight, relative to the total weight of the solution, essential oil of Melaleuca alternifolia in a solubilizing agent consisting of a mixture of coconut glyceryl oxyethylene, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water. According to another embodiment of the present invention, the antiseptic solution comprises from approximately 2% by weight to approximately 30% by weight, relative to the total weight of the solution, of geranium essential oil in a solubilizing agent consisting of a mixture of coconut glycerile oxyethylene, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water.
Selon une variante de réalisation de la présente invention, en particulier lorsque l'antiseptique utilisé possède une odeur pouvant être désagréable, la protection hygiénique selon l'invention comprend de plus un ou plusieurs parfums, tels que ceux utilisés de façon conventionnelle dans les produits cosmétiques. On citera à titre d'exemples non limitatifs de parfums utilisables dans le cadre de la présente invention les essences de citron, de muguet, de tangerine distillée, de jasmin ou de lavande.According to an alternative embodiment of the present invention, in particular when the antiseptic used has an odor which can be unpleasant, the hygienic protection according to the invention further comprises one or more perfumes, such as those conventionally used in cosmetic products . Mention will be made, by way of nonlimiting examples of perfumes which can be used in the context of the present invention, of the essences of lemon, lily of the valley, distilled tangerine, jasmine or lavender.
Par exemple, le ou les parfums peuvent être présents dans la protection hygiénique de l'invention, à une concentration variant entre environ 1 % et environ 5 % en poids par rapport au poids de l'antiseptique.For example, the perfume (s) may be present in the hygienic protection of the invention, at a concentration varying between approximately 1% and approximately 5% by weight relative to the weight of the antiseptic.
Selon une autre forme de réalisation de la présente invention, la protection hygiénique de l'invention comprend de plus un agent conservateur, protecteur à l'égard notamment des bactéries, des levures et/ou des champignons. Précisément, l'agent conservateur peut être utilisé à une concentration variant entre environ 0,1 % en poids et environ 1 % en poids par rapport au poids de l'antiseptique.According to another embodiment of the present invention, the hygienic protection of the invention further comprises a preservative, protective with regard in particular to bacteria, yeasts and / or fungi. Specifically, the preservative can be used at a concentration varying between about 0.1% by weight and about 1% by weight relative to the weight of the antiseptic.
On citera à titre d'exemple non limitatif d'agent conservateur utilisable dans le cadre de la présente invention, le produit disponible auprès de la Société Hassiauer, France, sous la dénomination commerciale « Bactiphen 2506 G ».
La solution antiseptique peut être déposée sur la protection hygiénique selon l'invention par tout moyen connu en soi. Par exemple la solution antiseptique est déposée par pulvérisation ou encore par buse léchante ou sans contact pendant le processus de fabrication de la protection hygiénique, de préférence à la fin de celui-ci.Mention will be made, by way of nonlimiting example of a preservative usable in the context of the present invention, of the product available from the company Hassiauer, France, under the trade name "Bactiphen 2506 G". The antiseptic solution can be deposited on the hygienic protection according to the invention by any means known per se. For example, the antiseptic solution is deposited by spraying or else by a licking or contactless nozzle during the manufacturing process of the hygienic protection, preferably at the end of it.
Par exemple, l'antiseptique est déposé avantageusement sur les éléments constitutifs de la protection hygiénique en contact avec la peau ou les muqueuses.For example, the antiseptic is advantageously deposited on the constituent elements of hygienic protection in contact with the skin or the mucous membranes.
Selon une autre forme de réalisation de la présente invention, l'antiseptique est déposé sur les éléments constitutifs de la protection hygiénique possédant une perméabilité suffisante pour permettre un transfert de l'antiseptique vers la peau ou les muqueuses et, ainsi un contact de l'antiseptique avec la peau ou les muqueuses.According to another embodiment of the present invention, the antiseptic is deposited on the constituent elements of the hygienic protection having sufficient permeability to allow a transfer of the antiseptic to the skin or the mucous membranes and, thus a contact of the antiseptic with the skin or mucous membranes.
Ainsi, dans le cas où la protection hygiénique est une couche- culotte infantile, l'antiseptique peut être déposé au niveau du voile interne.Thus, in the case where the hygienic protection is an infant diaper, the antiseptic can be deposited at the level of the internal veil.
Selon une autre forme de réalisation de la présente invention, l'antiseptique peut être déposé au niveau du voile intermédiaire.According to another embodiment of the present invention, the antiseptic can be deposited at the level of the intermediate veil.
Selon une autre forme de réalisation de la présente invention, l'antiseptique est déposé sur la protection hygiénique dans un état encapsulé dans un véhicule, par exemple dans un polymère lipophile lorsque l'on utilise un antiseptique huileux pur ou dilué dans une huile.According to another embodiment of the present invention, the antiseptic is deposited on the hygienic protection in a state encapsulated in a vehicle, for example in a lipophilic polymer when using an oily antiseptic pure or diluted in an oil.
De cette façon, les éventuels inconvénients posés par l'odeur que peuvent dégager certains antiseptiques sont éliminés.In this way, the possible drawbacks posed by the odor which certain antiseptics can give off are eliminated.
La technique d'encapsulation ou de micro-encapsulation utilisée dans le cadre de la présente invention est classique en elle-même et n'a pas besoin d'être décrite plus en détail ici.The encapsulation or microencapsulation technique used in the context of the present invention is classic in itself and does not need to be described in more detail here.
En variante, le ou les antiseptiques peuvent être déposés à l'aide de vecteurs habituellement utilisés dans l'industrie chimique ou cosmétologique, tels que liposomes ou phospholipides, pour permettre une action différée de l'antiseptique et/ou assurer un rôle de protection du principe actif vis-à-vis de l'extérieur.
Des avantages et caractéristiques supplémentaires de la présente invention apparaîtront encore à la lumière de la description plus détaillée qui suit d'un exemple de réalisation de ia présente invention, donné uniquement à titre illustratif et non limitatif. EXEMPLE :As a variant, the antiseptic (s) can be deposited using vectors usually used in the chemical or cosmetological industry, such as liposomes or phospholipids, to allow a delayed action of the antiseptic and / or to provide a protective role for the active ingredient vis-à-vis the outside. Additional advantages and characteristics of the present invention will become apparent in the light of the more detailed description which follows of an exemplary embodiment of the present invention, given solely by way of illustration and without limitation. EXAMPLE:
Sur une couche-culotte pour enfant comportant un voile interne de polypropylène hydrophile, une feuille extérieure de polyéthylène et une couche absorbante de ouate de cellulose entre te voile interne et la feuille extérieure, est déposée par pulvérisation une solution contenant 0,02 g d'huile essentielle de Melaleuca alternifolia en solution dans 0,04 g de l'agent solubilisant « Solubilisant 3 RS », disponible commercialement auprès de la Société Hassiauer, France et 0,5 g d'eau distillée.A solution containing 0.02 g of a spray solution is deposited on a children's diaper comprising an inner veil of hydrophilic polypropylene, an outer sheet of polyethylene and an absorbent layer of cellulose wadding between the inner veil and the outer sheet. essential oil of Melaleuca alternifolia in solution in 0.04 g of the solubilizing agent "Solubilizer 3 RS", commercially available from the Company Hassiauer, France and 0.5 g of distilled water.
Après conservation dans son emballage commercial pendant au moins un an à température ambiante, la couche-culotte montre une action positive contre les agents pathogènes Staphylococcus Curreus, Escherichia Coli, Pseudomonas Aeruginosa, Cnadida Albicans et Aspergillus Niger.After storage in its commercial packaging for at least one year at room temperature, the diaper shows a positive action against the pathogenic agents Staphylococcus Curreus, Escherichia Coli, Pseudomonas Aeruginosa, Cnadida Albicans and Aspergillus Niger.
Il va de soi que la présente invention n'entend pas se limiter à la forme de réalisation qui vient d'être décrite mais en embrasse au contraire toutes les variantes. L'homme du métier aura tout loisir de modifier certains des éléments de la présente invention sans pour autant sortir du cadre de ses caractéristiques essentielles, telles que décrites dans les revendications qui suivent.
It goes without saying that the present invention does not intend to be limited to the embodiment which has just been described but on the contrary embraces all variants. Those skilled in the art will be free to modify some of the elements of the present invention without going beyond the scope of its essential characteristics, as described in the claims which follow.
Claims
1. Protection hygiénique utilisable pour l'hygiène infantile, adulte et/ou l'hygiène médicale, comprenant au moins une feuille extérieure imperméable, un voile perméable et une couche absorbante disposée entre ladite feuille extérieure et ledit voile perméable, caractérisée en ce qu'elle comprend un ou plusieurs antiseptiques.1. Hygienic protection usable for infantile, adult and / or medical hygiene, comprising at least one impermeable outer sheet, a permeable veil and an absorbent layer disposed between said outer sheet and said permeable veil, characterized in that it includes one or more antiseptics.
2. Protection hygiénique selon la revendication 1 , caractérisée en ce que ledit antiseptique est choisi parmi les antiseptiques naturels.2. Hygienic protection according to claim 1, characterized in that said antiseptic is chosen from natural antiseptics.
3. Protection hygiénique selon la revendication 2, caractérisée en ce que l'antiseptique naturel est choisi notamment parmi les huiles essentielles d'origine végétale, par exemple les huiles essentielles de géranium, de lavande ou de citronnelle.3. Hygienic protection according to claim 2, characterized in that the natural antiseptic is chosen in particular from essential oils of plant origin, for example essential oils of geranium, lavender or lemongrass.
4. Protection hygiénique selon la revendication 2, caractérisée en ce que l'antiseptique naturel consiste essentiellement en huile de Melaleuca alternifolia.4. Hygienic protection according to claim 2, characterized in that the natural antiseptic consists essentially of oil of Melaleuca alternifolia.
5. Protection hygiénique selon ia revendication 2, caractérisée en ce que ledit antiseptique naturel consiste en un mélange comprenant essentiellement, en pourcentage par rapport au poids :5. Hygienic protection according to claim 2, characterized in that said natural antiseptic consists of a mixture essentially comprising, in percentage relative to the weight:
- environ 35 % de terpinne-1-ol-4 ; - environ 20 % de gamma terpinène,- about 35% of terpinne-1-ol-4; - around 20% gamma terpinene,
- environ 10 % d'alpha terpinène ;- about 10% of alpha terpinene;
- environ 5 % de cinéole ; et- about 5% of cineole; and
- environ 20 % de p-cymène.- about 20% p-cymene.
6. Protection hygiénique selon l'une quelconque des revendications 1 à 6, caractérisée en ce que l'antiseptique est déposé sous forme pure ou sous une forme de gel ou de poudre sèche ou sous une forme diluée, en solution aqueuse ou en solution anhydre.6. Hygienic protection according to any one of claims 1 to 6, characterized in that the antiseptic is deposited in pure form or in the form of gel or dry powder or in a diluted form, in aqueous solution or in anhydrous solution .
7. Protection hygiénique selon l'une quelconque des revendications 1 à 6, caractérisée en ce que l'antiseptique est déposé sous forme encapsulée ou est contenu dans un vecteur.7. Hygienic protection according to any one of claims 1 to 6, characterized in that the antiseptic is deposited in encapsulated form or is contained in a vector.
8. Protection hygiénique selon l'une quelconque des revendications 1 à 8, caractérisée en ce qu'elle comprend d'environ 0,2 mg à environ 20 g d'antiseptique.8. Hygienic protection according to any one of Claims 1 to 8, characterized in that it comprises from approximately 0.2 mg to approximately 20 g of antiseptic.
9. Protection hygiénique selon l'une quelconque des revendications 7 à 9, caractérisée en ce qu'elle comprend une solution antiseptique comprenant d'environ 1 % en poids à environ 10 % en poids, par rapport au poids total de ia solution, d'huile de Melaleuca alternifolia dans un agent solubilisant consistant en un mélange d'oxyéthylène glycérile de coprah, d'oxyéthylène de cétylstéaryl, d'oxyéthylène d'huilé de ricin hydrogénée et de l'eau distillée. 9. Hygienic protection according to any one of claims 7 to 9, characterized in that it comprises an antiseptic solution comprising from approximately 1% by weight to approximately 10% by weight, relative to the total weight of the solution, d 'Melaleuca alternifolia oil in a solubilizing agent consisting of a mixture of coconut glyceryl oxyethylene, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water.
10. Protection hygiénique selon l'une quelconque des revendications 7 à 9, caractérisée en ce qu'elle comprend un solution antiseptique comprenant d'environ 2 % en poids à environ 30 % en poids, par rapport au poids total de la solution, d'huile essentielle de géranium dans un agent solubilisant consistant en un mélange d'oxyéthylène glycérile de coprah, d'oxyéthylène de cétylstéaryl, d'oxyéthylène d'huile de ricin hydrogénée et de l'eau distillée.10. Hygienic protection according to any one of claims 7 to 9, characterized in that it comprises an antiseptic solution comprising from approximately 2% by weight to approximately 30% by weight, relative to the total weight of the solution, d geranium essential oil in a solubilizing agent consisting of a mixture of coconut oxyethylene glycerol, cetylstearyl oxyethylene, hydrogenated castor oil oxyethylene and distilled water.
11. Protection hygiénique selon l'une quelconque des revendications 1 à 10, caractérisée en ce qu'elle comprend de plus un parfum.11. Hygienic protection according to any one of claims 1 to 10, characterized in that it further comprises a perfume.
12. Protection hygiénique selon la revendication 11, caractérisée en ce que le parfum est présent à une concentration d'environ 1 % à environ 5 % en poids par rapport au poids de l'antiseptique.12. Hygienic protection according to claim 11, characterized in that the perfume is present at a concentration of approximately 1% to approximately 5% by weight relative to the weight of the antiseptic.
13. Protection hygiénique selon l'une quelconque des revendications 1 à 12, caractérisée en ce qu'elle comprend de plus un agent conservateur, à une concentration variant entre environ 0,1 % en poids et environ 1 % en poids par rapport au poids de l'antiseptique.13. Hygienic protection according to any one of claims 1 to 12, characterized in that it further comprises a preservative, at a concentration varying between approximately 0.1% by weight and approximately 1% by weight relative to the weight antiseptic.
14. Protection hygiénique selon l'une quelconque des revendications 1 à 13, caractérisée en ce que l'antiseptique est déposé au niveau des éléments constitutifs de ladite protection en contact avec la peau ou les muqueuses. 14. Hygienic protection according to any one of claims 1 to 13, characterized in that the antiseptic is deposited at the level of the constituent elements of said protection in contact with the skin or mucous membranes.
15. Protection hygiénique selon l'une quelconque des revendications 1 à 13, caractérisée en ce que l'antiseptique est déposé au niveau des éléments constitutifs de ladite protection hygiénique possédant une perméabilité suffisante pour permettre un transfert de l'antiseptique vers le peau ou les muqueuses.15. Hygienic protection according to any one of claims 1 to 13, characterized in that the antiseptic is deposited at level of the components of said hygienic protection having sufficient permeability to allow transfer of the antiseptic to the skin or mucous membranes.
16. Protection hygiénique selon la revendication 14 ou 15, caractérisée en ce que l'antiseptique est déposé au niveau du voile interne ou du voile intermédiaire.16. Hygienic protection according to claim 14 or 15, characterized in that the antiseptic is deposited at the level of the internal veil or the intermediate veil.
17. Protection hygiénique selon l'une quelconque des revendications 1 à 15, consistant notamment en une couche-culotte infantile, une couche-culotte pour adulte, une couche-culotte médicale, une couche pour incontinence, une serviette périodique. 17. Hygienic protection according to any one of claims 1 to 15, consisting in particular of an infant diaper, an adult diaper, a medical diaper, a incontinence layer, a period towel.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97918240A EP1021213A1 (en) | 1996-04-15 | 1997-04-15 | Improved sanitary pad |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604670A FR2747310B1 (en) | 1996-04-15 | 1996-04-15 | IMPROVED HYGIENIC PROTECTION COMPRISING AN ANTISEPTIC |
FR96/04670 | 1996-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997038738A1 true WO1997038738A1 (en) | 1997-10-23 |
Family
ID=9491192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1997/000683 WO1997038738A1 (en) | 1996-04-15 | 1997-04-15 | Improved sanitary pad |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1021213A1 (en) |
FR (1) | FR2747310B1 (en) |
WO (1) | WO1997038738A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064083A1 (en) * | 1998-06-11 | 1999-12-16 | Mcneil-Ppc, Inc. | Disposable absorbent article containing an essential oil |
US6749860B2 (en) | 2000-12-22 | 2004-06-15 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with non-aqueous compositions containing botanicals |
US6756520B1 (en) | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
ES2255876A1 (en) * | 2004-06-28 | 2006-07-01 | Grupo P.I. Mabe, S.A. De C.V. | Utilisation of essential oils in disposable e.g. nappies comprises top coating with an e.g. chamomile geranium eucalyptus and sandalwood oils mixture |
US7771735B2 (en) | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19926431A1 (en) * | 1999-06-10 | 2000-12-14 | Basf Ag | Absorbent mixture |
US7799966B2 (en) | 2000-04-14 | 2010-09-21 | Playtex Products, Inc. | Fibrous absorbent articles having malodor counteractant ability and method of making same |
FR2829936B1 (en) * | 2001-09-27 | 2003-11-28 | Sederma Sa | USE OF THE MIXTURE OF MELALEUCA ALTERNIFOLIA OIL AND AVOCADIN INCORPORATED IN MICROCAPSULES FIXED ON ANY TEXTILE TO FIRM THE SKIN |
EP1432458A1 (en) * | 2001-10-02 | 2004-06-30 | Kimberly-Clark Corporation | Inhibition of exoproteins using isoprenoids |
US8084046B2 (en) | 2001-10-02 | 2011-12-27 | Kimberly-Clark Worldwide, Inc. | Inhibition of exoprotein production in absorbent articles using isoprenoids |
US6596290B2 (en) | 2001-10-02 | 2003-07-22 | Kimberly-Clark Worldwide, Inc. | Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions |
US6534548B1 (en) | 2001-10-02 | 2003-03-18 | Kimberly-Clark Worldwide, Inc. | Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria |
US20030224034A1 (en) * | 2002-05-31 | 2003-12-04 | Koenig David W. | Personal care article and method for inhibiting attachment of yeast to skin |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE544098A (en) * | ||||
FR999074A (en) * | 1948-11-13 | 1952-01-28 | Sanitary napkin and its manufacturing process | |
GB894832A (en) * | 1958-03-24 | 1962-04-26 | Upjohn Co | Improvements in or relating to medicated products |
US3490454A (en) * | 1966-10-21 | 1970-01-20 | United Merchants & Mfg | Catamenial products having a coating of rupturable microcapsules containing medicants |
LU64742A1 (en) * | 1972-02-07 | 1973-08-21 | ||
GB2083748A (en) * | 1980-09-17 | 1982-03-31 | Landstingens Inkopscentral | Germicidal absorbent body or pad |
WO1990012555A1 (en) * | 1989-04-27 | 1990-11-01 | Giovanni De Francesco | Sanitary towel and similar objects with antiseptic properties |
JPH0312165A (en) * | 1989-06-09 | 1991-01-21 | Ube Ind Ltd | Deodorant consisting of tree oil as effective component |
FR2691067A1 (en) * | 1992-05-18 | 1993-11-19 | Difinter Sa | External article for absorbing menstrual fluid - contains antimicrobial and odour masking agent dissolved or suspended in low volatility solvent |
-
1996
- 1996-04-15 FR FR9604670A patent/FR2747310B1/en not_active Expired - Fee Related
-
1997
- 1997-04-15 WO PCT/FR1997/000683 patent/WO1997038738A1/en not_active Application Discontinuation
- 1997-04-15 EP EP97918240A patent/EP1021213A1/en not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE544098A (en) * | ||||
FR999074A (en) * | 1948-11-13 | 1952-01-28 | Sanitary napkin and its manufacturing process | |
GB894832A (en) * | 1958-03-24 | 1962-04-26 | Upjohn Co | Improvements in or relating to medicated products |
US3490454A (en) * | 1966-10-21 | 1970-01-20 | United Merchants & Mfg | Catamenial products having a coating of rupturable microcapsules containing medicants |
LU64742A1 (en) * | 1972-02-07 | 1973-08-21 | ||
GB2083748A (en) * | 1980-09-17 | 1982-03-31 | Landstingens Inkopscentral | Germicidal absorbent body or pad |
WO1990012555A1 (en) * | 1989-04-27 | 1990-11-01 | Giovanni De Francesco | Sanitary towel and similar objects with antiseptic properties |
JPH0312165A (en) * | 1989-06-09 | 1991-01-21 | Ube Ind Ltd | Deodorant consisting of tree oil as effective component |
FR2691067A1 (en) * | 1992-05-18 | 1993-11-19 | Difinter Sa | External article for absorbing menstrual fluid - contains antimicrobial and odour masking agent dissolved or suspended in low volatility solvent |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 9109, Derwent World Patents Index; AN 91-062523, XP002021435 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064083A1 (en) * | 1998-06-11 | 1999-12-16 | Mcneil-Ppc, Inc. | Disposable absorbent article containing an essential oil |
US6284261B1 (en) | 1998-06-11 | 2001-09-04 | Mcneil-Ppc, Inc. | Disposable absorbent article containing an essential oil |
US6756520B1 (en) | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
US6749860B2 (en) | 2000-12-22 | 2004-06-15 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with non-aqueous compositions containing botanicals |
US7771735B2 (en) | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
ES2255876A1 (en) * | 2004-06-28 | 2006-07-01 | Grupo P.I. Mabe, S.A. De C.V. | Utilisation of essential oils in disposable e.g. nappies comprises top coating with an e.g. chamomile geranium eucalyptus and sandalwood oils mixture |
Also Published As
Publication number | Publication date |
---|---|
FR2747310B1 (en) | 1998-06-05 |
FR2747310A1 (en) | 1997-10-17 |
EP1021213A1 (en) | 2000-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0279328B1 (en) | Perfuming composition with a deodorizing or antiperspirant activity | |
EP1021213A1 (en) | Improved sanitary pad | |
EP0091368B1 (en) | Compositions capable of fighting transpiration harm and inconveniences | |
CA1096771A (en) | Complexes insectifuges | |
LU87551A1 (en) | NATURAL PRESERVATIVE COMPOSITION FOR WET TOWELS | |
WO1993025185A1 (en) | Perfumed composition | |
US20060216365A1 (en) | Aromatherapeutic environmental system | |
WO2009153419A1 (en) | Composition comprising natural microencapsulated extracts for oral, skin, or mucosa application | |
WO1992000722A1 (en) | Alcoholic fragrance composition | |
EP1606036A2 (en) | Universal insecticide and insect-repellent and method for production thereof | |
JP2003153945A (en) | Sanitary article | |
KR20200064622A (en) | Cosmetic composition with deodorization and antimicrobial effect containing complex extract of peppermint, oregano, ginger and cinnamon | |
FR2640502A1 (en) | ||
US11376201B2 (en) | Micellar extended release nanostructures | |
JP2019531267A (en) | Antimicrobial composition | |
JP2009195185A (en) | Beverage for reducing halitosis | |
JP2001302495A (en) | Skin-cleansing agent and skin-cleansing supplies | |
US20060171914A1 (en) | Botanically derived cleanser | |
EP2774669B1 (en) | Absorbent article | |
EP3434223A1 (en) | Dental hygiene wipes comprising microcapsules | |
Mohammed et al. | THERAPEUTIC BENEFITS OF SELECTED PLANT HERBS WITH ESSENTIAL OILS USED IN COSMETIC FORMULATION | |
JP3024392U (en) | Miscellaneous cargo with ghetto composition | |
EP3366122B1 (en) | Use of odorous polymer matrices for litters | |
WO1995015146A1 (en) | Aqueous scented composition | |
WO2021160613A1 (en) | Deodorant composition containing 1,8-para-menthenethiol, 3-mercaptohexyl acetate and undecylenic acid or the derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997918240 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997918240 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997918240 Country of ref document: EP |